CVC  Illumina Ventures

http://www.illuminaventures.com/





     Office Locations:

200 Lincoln Centre Drive, Suite 300-A
Foster City, CA 94404
Phone: 858-210-1824

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early


 

Industries:

  • Food & Agriculture
  • Life Sciences & Healthcare

  •  

    Description:

    Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. Illumina provides the majority of their capital and access to the expertise and vision of the world's leading genomics solutions provider. The firm invests primarily in early stage companies and typically syndicates with other leading institutional and strategic investors. Focus areas include applications of genomics in life science research, healthcare, agriculture and environmental science, public safety and personal wellness. Illumina Ventures was launched in the summer of 2016 with an initial $100 million investment from Illumina. The balance of the funds have been raised from a mix of corporate, institutional, sovereign, and individual investors. The firm closed on $230M for its first fund.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Donal Delaney Chief Financial Officer
    Jessica Wong Controller
    Nick Naclerio PhD Founding Partner
    Tom Willis PhD Partner
    Wouter Meuleman PhD Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/03/2023


      Iambic Therapeutics


      CA


      $100,000,000


      Series B


      04/27/2023


      Pattern Bioscience


      TX


      $28,700,000


      Series C


     

    Portfolio companies include:


      Actym Therapeutics
        web link


      Alamar Biosciences
        web link


      Attovia


      Cernostics


      Delfi


      Delfi Diagnostics
        web link


      Genome Medical
        web link


      Iambic


      Iambic Therapeutics
        web link


      Kallyope
        web link


      LetsGetChecked
        web link


      Lightcast


      Luna DNA
        web link


      LunaPBC
        web link


      Mantra Bio
        web link


      NanoCellect Biomedical
        web link


      Pattern Bioscience
        web link


      Pluton Biosciences


      Preced Biosciences


      Protillion Biosciences
        web link


      Rebus Biosystems


      Redshift Bio


      Ribometrix
        web link


      SerImmune
        web link


      Sherlock Biosciences
        web link


      SonoThera
        web link


      SQZ Biotech
        web link


      Stilla


      Walking Fish Therapeutics
        web link


     

    Recent News: